iMEDD recently relocated from San Francisco's Silicon Valley to The Ohio State University's Science and Technology Campus Corporation (Scitech) for the launch of its drug delivery business. iMEDD is providing proprietary nanoporous membrane filter technology to the R&D collaboration with Battelle.

One of the key patent holders is Professor Mauro Ferrari, who currently holds more than 20 patent and patent applications in this technology area. Ferrari is now a professor of internal medicine, mechanical engineering and materials science at OSU, as well as director of the Biomedical Engineering Center, and associate director of the Heart and Lung Institute.

This filter technology provides a means for fabricating membranes with highly uniform pore sizes in the nanometer range. The pore size and density can be accurately controlled to achieve the desired rate of diffusion for different biological drugs.

"iMEDD is thrilled to be able to join forces with Battelle on this project," said Carl F. Grove, iMEDD's President. "This agreement allows iMEDD to focus on development of its nanomembranes while collaborating with Battelle to bring the technological skills and resources needed to develop a prototype drug delivery implant." Battelle is providing its unique polymer chemistry design and fabrication expertise, controlled release expertise, and pharmaceutical testing laboratories to this collaboration with iMEDD. Battelle's research staff have experience selecting, designing, and fabricating novel polymeric structures used as implantable devices, as well as experience in testing the drug delivery potential of such devices.

"iMEDD presents an opportunity to change the face and future of medicine. We are excited to participate in the early development of this significant technology," said Steve Stein, Battelle's Technology Platform Leader. At the conclusion of this R&D collaboration, iMEDD and Battelle will seek partnerships with biopharmaceutical companies to initiate drug-specific development programs.

For further information please contact Carl Grove of IMEDD, Inc. at (614) 675-3653 or grove@ispchannel.com; Katy Delaney of Battelle at (614) 424-5544 or delaneyk@battelle.org; or Ora E. Smith of Scitech at (614) 675-4100 or osmith@stcc.org.

NOTES TO EDITORS

iMEDD, Inc.

iMEDD, Inc. is an emerging drug delivery company based on proprietary micro-engineering technology developed by Professor Mauro Ferrari, Director of the Biomedical Engineering Center at The Ohio State University.

iMEDD, Inc. is located in the Science Village, a high technology research park on the campus of The Ohio State University. Construction is currently underway for the first building in this complex which will house iMEDD and the Ohio MicroMD laboratory. This 20,000-square-foot facility has been designed as the country's first facility dedicated to R&D of therapeutic applications of BioMEMS. For more information, visit www.stcc.org.

Battelle

See the back of page one, or visit www.battelle.org, for more information.

Science and Technology Campus Corporation (Scitech)

The Science and Technology Campus at The Ohio State University is a free-standing, not-for-profit corporation governed by an eleven-member Board of Directors composed of civic, business, and university leaders. Scitech is creating an environment where new and rapidly growing technology-based companies can transform knowledge - derived from the university and community's technology base - into products, processes and services. For more information, visit www.stcc.org.